Enter your search term above.

News

October 2019

If Joe Buckheit’s son hadn’t needed hernia surgery, Joe might not be here today.

At 49 years old, Joe was a proud father of three – two girls aged 12 and 10, and 6-year-old Michael. Joe is the kind of dad who, when he found out about Michael’s hernia, decided to have a non-painful lump in his own groin checked out. He volunteered to have the procedure first, “to show him it would be okay.”

To everyone’s surprise, pre-surgical testing revealed a mass in the lower right lobe of Joe’s lung. A routine procedure suddenly turned into something more urgent. “Off we go with my scans to MSK,” Joe remembered. “The nurse does the intake and tells me the doctor will be right in. Then I look and see Doogie Howser standing there – the doctor was so young! He was incredibly supportive and went right to doing a whole bunch of tests. I thought, ‘This is the place for me.’”

He went into surgery expecting that it would be the only treatment he’d need. “I went under at 6 PM. I woke up in the recovery room and looked up at the clock. It was 7:30. I hoped it was morning, because otherwise he hadn’t done the surgery.” Joe’s lung cancer had spread to the lymph nodes, and he was going to need much more extensive treatment.

Joe brought his wife and her sister – a nurse – to the oncologist, armed with a list of questions. “I had a friend who had been diagnosed with lymphoma and had been given a 98% survival rate,” he explained. “So in my head, I thought maybe my chances were 50/50. I asked the doctor the success rate for my Stage 3B cancer, and he said 17%. I figured he heard me wrong and thought I had asked him the failure rate, but no – he was telling me that I had a 17% chance of being alive in five years.”

“I like to have the best case and worst case scenario, so I asked what would happen if I did nothing. He said I’d likely be dead in five or six months.”

Joe was determined to do what he could to stay alive for his family. His wife was instrumental in his treatment, setting up his appointments and tracking his medication. His sister-in-law lent her support, and his friends made sure he got out of the house.

Joe had two rounds of chemo and one round of radiation, going to work every day other than treatment days. “I wanted to show the kids things were OK.” Despite the sense of stability, they knew Joe had a serious condition. At Christmas, his son wrote a letter to Santa.

I do not want you to give me any thing from you. I want it from God. I will tell you what I want from God. I want my daddy’s cancer to go away so if I find not one present under my tree I will know my daddy’s cancer is gone.

It broke Joe’s heart, but the answer – which came from a stranger answering letters from children on behalf of Santa – was astonishing.

Dear Michael,
Merry Christmas! Rudolph, Ozzie the Elf and Mrs. Claus all say “hello.”Your wish moved me greatly. Most people ask me for toys – things you can wrap up and put under a tree or in a stocking. But your wish is too big to be put in a box and wrapped with a bow. It’s a wish that’s as big as the heart that wished it. I’ll be thinking of you when I get ready to deliver my presents on Christmas Eve – the child who wished for more than just toys. You yourself are a gift to the world.

Joe carries a copy of that letter with him.

About two years into Joe’s lung cancer journey, he felt a pain in his right leg and collapsed in the kitchen. His sister-in-law urged him to see a doctor immediately in case it had been a stroke. The cancer had metastasized to Joe’s brain. He had a tumor in the left lobe and two smaller ones on the right – he now had Stage 4 lung cancer. After diagnosis, he had whole brain radiation and then brain surgery. He continued with annual MRIs with a neurologist and CT scans with his oncologist.

A few months ago, Joe’s neurologist said something remarkable during a routine exam: “I think you’re cured.” Annual MRIs are now optional. His oncologist continues to monitor him, but Joe says he feels great except for ongoing balance issues from the brain radiation.

What may be most remarkable of all is that 15 years have passed since Joe’s initial diagnosis. Michael is now 21 years old, and Joe is 64.

joe buckheit

In 2005, the year after Joe found out he had lung cancer, he signed up for the inaugural Strides for Life. The family of his friend with lymphoma has a summer house in the Hamptons, and they gathered there after the walk. “I’ve done it every year since then,” he said. “The most difficult was right after the whole brain radiation. Normally I’d run a little and walk a little, but I was very unsteady. I said, ‘If I have to crawl across the finish line, I will.’ I had one friend on each side, and I finished dead last with the cop car behind me.” The Buckheit Brigade is growing and going strong!

How has Joe maintained hope over the past 15 years? “I’m not a guy who is outwardly emotional,” he said. “There are times when I would look at myself and say, ‘You think you’re so freaking tough, prove it.’ I know people ask, ‘Why did I get this?’ My question is, ‘Why didn’t I die?’”

Joe looks forward to the day when luck is no longer a factor, and noted how lung cancer research has transformed the way the disease is diagnosed and treated. The tests that would have revealed a treatable mutation in his lung cancer didn’t exist in 2004. Patients today have more options than ever. “If you’re newly diagnosed, trust your doctors. They know things that they never knew before,” he observed. “Try not to miss any treatments in order to give yourself the best chance to succeed.”

November 2016 | As told by Jennifer

A year and a half ago, I was feeling terribly run down and getting very winded from normal activities in spite of being fit and athletic. I was coughing, having trouble catching my breath, and experiencing some mild wheezing. These symptoms led me to my primary care physician, and when I didn’t feel better on antibiotics within a few days, she ordered a chest x-ray.

On a busy Saturday, I let my husband Andy manage our kids’ sports schedules and walked myself into the emergency department, expecting a case of walking pneumonia or bronchitis. Nothing could have surprised me more that day than to learn that I have Stage IV metastatic lung cancer.

As a lifelong athlete through college and now just “for fun,” I couldn’t understand how someone who follows a healthy diet, exercises regularly, and competes in triathlon and running events could possibly have incurable lung cancer.

I fought during the next month to become well enough to begin chemotherapy, knowing that statistically I would be an outlier if I could survive beyond a year or two. But 17 months after diagnosis, I am living very well as I continue chemo to keep the cancer in my lungs stable. The cancer that was found initially in my adrenal gland and liver is now undetectable.

Unfortunately, debilitating headaches and vomiting six months ago led to the identification of two lesions in my brain. Both were successful removed via craniotomy. Four months later, as I was once again feeling my “new normal,” MRI identified another brain lesion, which was successfully treated with stereotactic radiosurgery. I have recovered from these detours and use them as an opportunity to refocus on my overall wellness – which I know not to take for granted. I have maintenance chemotherapy every three weeks and MRI of my brain every few months to check for cancer growth. Despite these challenges, I have been determined to take control of the only thing that I can control: my mindset and gratitude each day.

Today, I have resumed most of my normal activities while working around the many side effects and appointments: managing the household and parenting our 15-, 12-, and 10-year-olds; coaching (and playing) volleyball; practicing yoga and walking our dogs; volunteering at my children’s school and being active in our church; and enjoying the daily joys of carpools and family dinners.

I am constantly challenged to accept the limitations that living with lung cancer places on my life and the emotional fear that can easily take hold if I am not vigilant in choosing to focus on the beauty in each day rather than worrying about the days to come. I work very hard to draw from my faith, practicing meditation and prayer focusing on how great my life is rather than how terrible my diagnosis is.

I have become as knowledgeable as possible about lung cancer in order to advocate for myself with all the members of my medical team, and I eagerly pay attention to research findings that I hope will help me and many others live better and longer with lung cancer.

Andy, my amazing husband of 22 years, has been instrumental in helping us navigate life with lung cancer, as have our parents and siblings. My sister (a nurse) and countless members of our community have supported me in so many ways: meals, play dates for the kids, a volleyball tournament fundraiser, encouraging prayers/emails/text messages/phone calls, and joining me to walk the 2016 Kansas City Free to Breathe 5K and helping our Team Gratitude raise the second greatest amount of money of any team at the event this year.

I feel an urgency to share information about lung cancer since it is so largely overlooked, especially in light of the fact that lung cancer claims more lives each year than breast, colon and prostate cancer combined. I tell my story to anyone who will listen, hoping that I can be part of a movement to increase funding for lung cancer research so that it might one day receive funding proportionate to the impact it has when compared with other cancers.

Lung cancer does not discriminate; financial support shouldn’t either.

No one deserves lung cancer, and I want to help end the negative stigma unfairly attached to lung cancer and help raise funding to find a cure. I hope to increase my advocacy efforts now that I am back on a predictable schedule of chemo every three weeks. I know that for me and many others, we are in a race between our cancer growth and research breakthroughs.

In the short time since my diagnosis in April 2015, the landscape has changed tremendously as researchers discover new breakthroughs. The options are broader for anyone diagnosed today. I encourage anyone living with lung cancer to ask questions of doctors or reputable organizations; to access palliative care, psychology, nutrition and other resources to complement oncology; to ignore the larger internet or “hearsay” information; and to focus on how you can make each day beautiful.

Living with cancer forces patients to acknowledge how little control we each have, but the one thing we can control is the attitude we carry and share with others. Choose to be a person of gratitude who lives in the present and takes charge of living a quality of life filled with hope. When I remain too long in that dark place of worrying about myself, all I need to do is look around the waiting room at the cancer center and see how many others are suffering more than I am today. It is only in my mind and heart that I can control this cancer by allowing it to fuel hope, gratitude, and love – instead of letting it take away my joy.

May 2019

Jen and Kids

Jen is someone most people would describe as a supermom: active and on the go with three children ages 4-10. That’s why she was surprised when she couldn’t shake the post-nasal cough she developed over the summer of 2017. “I hadn’t been feeling great and thought allergies were the problem. I almost never get sick, though,” she recalled. “I took a full course of antibiotics and somehow felt worse afterwards. They took a chest x-ray and the results showed some abnormalities.” Things escalated quickly from there.

Jen was admitted to the hospital after her neck became so swollen that she had difficulty breathing. Eight days later, the doctor broke the news that Jen had a mass in her lungs—one that was indicative of lung cancer. “What do you mean, I have lung cancer? This is crazy!” Jen recalled thinking after hearing she was facing stage IV non-small cell lung cancer at the age of 38.

Many people don’t think of lung cancer as a women’s issue. What they don’t realize is that lung cancer claims the lives of more women than breast, ovarian, and cervical cancers combined.

Fortunately for Jen, her healthcare team performed biomarker testing on her tumor, which tested positive for the cancer-causing ALK genetic mutation. This insight opened up Jen’s options for treatment. “They put me on alectinib (Alecensa®), which helps treat ALK positive lung cancer tumors. It helped shrink and then stabilize the growth of my tumor,” she explained. “After just four days of being on alectinib, I felt great and I haven’t looked back since.” Jen has fondly nicknamed alectinib her “miracle drug.”

And Jen’s zest for life never wavered. She searched the internet for ways to connect with other ALK positive lung cancer patients and advocate for more research behind life-saving lung cancer treatment options. Jen joined two patient advocacy groups, ALK+ and ALK Fusion. “We figured, let’s take matters into our own hands,” Jen recalled discussing in her group meetings. “I want doctors to understand the patient experience more, and there’s so much positivity that can arise from collaborating with them.” Today, Jen takes a stand for better lung cancer treatment by fundraising—she helped organize and fundraise almost $700,000 so far—and by sharing her story at conferences and community events.

“At the end of the day we are people, and we all want the same thing. We need more treatment options so we do not have to constantly face this idea of the ‘end of the road.’ I’m just trying to save my life, and my life is in the hands of science.”

“I need medicine, here and now. I will do anything to stay here with my children. This is my reason.”

Jen channels her energy into reading up on the latest lung cancer research and traveling to speak with oncologists, researchers and community members to emphasize the urgency of being able to live beyond a lung cancer diagnosis.
“Every day is a new day and a new chance,” she explained.

July 2019 | As told by Felicia

Felicia

Like most people, I had my normal routine – kind of on autopilot, like the robots we become. One day, I wasn’t feeling like myself, but I did the robotic thing and went to work as usual. I felt like I had a bad cold coming on and it was very hard to breathe, so I took a long lunch and planned a trip to urgent care.

When the nurse checked my vitals, she asked how I managed to get to the clinic by myself operating on only 30% oxygen. She was surprised I wasn’t in a coma. I went by ambulance to University Hospital and spent three days in the ICU, diagnosed with pulmonary edema and high blood pressure. I was put on continuous oxygen and told it would only be needed for a few weeks. But several follow-up visits later, nothing had changed. I was scared and fed up, so I was a little assertive: “I’m not leaving here today with the same information you’ve been telling me the last few visits. I do not feel good, and I need to know what the h*ll is wrong with me!”

The medical staff conferred for about a half hour and sent me for a CT scan, which confirmed a fist-sized tumor and lesions throughout both my lungs. I didn’t get to go home – I was immediately admitted to the oncology floor. Three days later, after numerous tests and five liters of fluid drawn from my lungs, I was diagnosed with stage IV lung cancer.

That was on February 7, 2017. I had never smoked, and lung cancer came as a complete surprise. I felt like my whole world had crashed. I kept trying to play back in my head: were there any symptoms, was there anything out of the norm I had missed? Why me?

The next year, I was in and out the hospital with pneumonia, rhinovirus, and a blood infection. I had two types of chemo plus radiation to shrink my tumor because its position was causing my repeated bouts with pneumonia. The last round of chemo was aggressive. My hair was gone in two weeks, and I lost much of my hearing – 70% in my left ear, 30% in my right. It never returned, so I wear a hearing aid.

In December 2017, my oncologist found a clinical study that was available for adenocarcinoma patients like me. I jumped on the chance without hesitation. I just needed to try something new that might make a difference without all the side effects I’d been experiencing. The medication is a pill without a name, just a protocol number. About 250 people in the U.S. are taking it. My side effects are diarrhea and mild headaches, which is nothing compared to what I had gone through: fatigue, neuropathy, nausea, skin rashes, hair loss, and hearing loss. The tumor has shrunk about 20% since I started the trial, and I was able to go back to my job at Core-Mark International part-time in April 2018 after being on medical leave for over a year. I have worked since the age of 16, and I hated being away from my job for so long. That August, I went back to full time. I was promoted to Customer Service Manager and received the 2018 Employee of the Year Award.

Work takes my mind off my illness, and my co-workers have given me a lot of support. Core-Mark held a fundraiser and a silent auction on my behalf last summer at a ranch and raised over $5,000. I still can’t believe how much my life has changed. Having some normalcy helps me get through it all. I found LCRF when I volunteered to help with a Free to Breathe Walk in my city, and I was glad to do something to promote awareness of lung cancer and the need for research.

I thank God for every day that my name is on the wake-up list. It’s so easy to let cancer take over, mind, body and soul. I try to be a living testimony for people, to help encourage others with my drive and energy to fight.

Cancer picked me; I didn’t pick cancer. I tell everyone that cancer picked the wrong girl! I am a soldier who can’t stop — and won’t stop. I love being a voice for lung cancer and welcome the chance to talk about my journey. I’m lucky to have the support system from my family and friends. I believe and know that I am truly blessed.

Elizabeth de Jong passed away on July 3, 2023 from complications caused by Stage IV lung cancer.


July 2017 | As told by Elizabeth de Jong

On September 16, 2016, my life took a sharp right turn. I had been having some hip pain over the summer and it had stretched down into my thigh by August. A visit to the orthopedist resulted in one of those awesome “women at your age” conversations and a shot for bursitis. The x-ray had stopped just shy of the tumors that were in my femur. A few days before I was due for a follow up appointment with the orthopedist, my femur broke as I was going down the stairs in my house. At the hospital in viewing my x-rays, the same orthopedist, feeling bad that he hadn’t caught them the first time he saw me in August, saw the tumors and ordered an MRI and more x-rays. He didn’t like what he saw and referred us to a comprehensive cancer center of our choosing. After nearly a week of more x-rays and CT scans and MRIs, and a bronchoscopy, I was told I had non-small cell lung cancer, stage IV. In addition to the femur, they had found tumors in the lower lobe of my right lung, lymph nodes near it and a lesion in my brain. Shocked doesn’t even begin to describe how I felt. Shocked not only at the diagnosis but also in disbelief because, other than the hip and leg pain, I’d had no symptoms – no shortness of breath, no coughing, no pain, no headaches, no vision issues, nothing.

When I heard those words “lung cancer” I thought the typical thoughts – I’m too young. I don’t want to die yet. My world stopped rotating and for a moment, the only things I could feel were the pain and fear in my heart and my husband’s hand in mine. Then the world came back into focus and my amazing medical team from Hillman Cancer Center at the University of Pittsburgh Medical Center rallied around me. My biopsies and blood were sent out for genomic testing. I was scheduled for cyber knife on my brain and radiation on my now-repaired and titanium reinforced leg. As we wrapped up the radiation treatments, my genomic testing came back and I was told I’d hit the “jackpot” of NCSLC – ALK – non small cell lung cancer with the anaplastic lymphoma kinase mutation. Fewer than 5% of all NCSLC diagnosis share this trait but research has created a great window of treatment opportunities.

My husband is my co-fighter, my warrior, my researcher, my advocate, my laughter, my shoulder to cry on, and my true partner. I refer to “our” oncology appointments because he never misses one. He’s been with me for every treatment, as close as the radiation techs would allow – far down the hallway behind the lead walls but still with me every step of the way. But that is just the details of what he does, what doesn’t come through is how much my love has grown for him since we started this journey. He helps me in more ways than I can even try to articulate. Together, we stay as positive as possible: enjoy good food, friends, travel and much much more. He knows when I’m struggling and can appropriately be my cheerleader or, if needed, remind me to get over myself.

Chemotherapy

My treatment is an “oral chemo” or, more appropriately, a tyrosine-kinase inhibitor. I started, for just a few weeks with Xalkori®, crizotinib, but quickly transitioned to Alecensa®, alectinib. It better crosses the blood/brain barrier and since I’d already had one lesion, our oncology team decided to make the switch. My oncologist strikes a good balance between realist and optimist. We talk about not only my current treatments but what will come next or down the line from that. He’s explained about TKI immunity or failure. We’ve talked about options for other TKIs, other therapies, potential trials, if appropriate, and additional biopsies and testing when failure happens (a reality – whether this year or next year or the next). I’m hoping for a good long run on alectinib but also keep in the back of my mind that eventually its effectiveness will come to an end.

I’ve been fortunate to have very few side effects from either the radiation or the daily regimen of oral chemo. One of the challenges, I think, that cancer patients face as medical science advances is that we don’t look like “typical” movie or tv cancer patients. I haven’t, and won’t, lose my hair with this treatment; I am able to work full time, travel and work out. Because I have not received “traditional” chemotherapy, I don’t have a port and I don’t have many of the side effects most people think of when they think of cancer. I do get tired more easily. I do have some muscle and joint aches and pains as a side effect of the alectinib. The alectinib is a photosensitive drug and I’ve learned that SPF 50 won’t cut it for me anymore. I don’t have any dietary restrictions and, other than my own sweet tooth that goes back to way before my cancer diagnosis, am able to eat a normal diet.

Another challenge I faced was getting off the walker, and then off a cane, after my femur repair. This took a lot of time and I had to be patient and remind myself that I couldn’t expect “normal” results because I was no longer normal. I was not only healing a broken femur but fighting the cancer in the bone, and the rest of my body, and dealing with the radiation to my femur as well. I had great days where I would do so much more than I thought I could the day before and then days where I struggled to even do the bare minimum to get through the day.

I’m fortunate that we have both access to and resources for complimentary therapies – regular yoga, acupuncture, therapeutic massage and physical therapy/training sessions along with a naturopath and nutritionist as needed. Other than that pesky cancer, I’m probably healthier than I have been at any other time in my adult life.

Celebrating life in 3-month increments

There are days when I could ALMOST forget I have cancer. I feel strong and healthy. But then it’s time to take another medication or supplement and I’m reminded. In addition to daily workouts, trying to eat a more healthy diet, and my medication regimen, I’ve added a few other activities. I journal nightly. I track symptoms and side effects in my journal, in addition to my emotions or daily activities. I also keep a daily prayer list of people I want to include in my thoughts and prayers that day – some people are, and have been, on that list daily since I started, others come and go based on what I see on social media, what is shared with me in conversation or just a feeling I might get about that person. That prayer list also includes prayers for me – –vary from day to day as well. I try to think positively, that I’m doing well and the treatments are working. But there are times that the reality sinks in. I worry about what progression may look like for me, since each person’s journey is different. I worry about having to tell my family and friends about that progression. I find myself trying to reinforce to people that I’m fine, while in my head I’m thinking “I’m fine, for now.” But I don’t want to bring people down.

I let myself have small pity sessions from time to time but then I try to move past it. I think about the trips I can still take (can you tell my husband and I love to travel?), the time with friends and family that I still have, the mundane day-to-day events I still have in front of me, and all the good things ahead of me. We celebrate life in 3-month increments between scans.

I received some great pieces of advice from various people when I started this journey. I met a gentleman a few months ago while I was waiting for my first follow-up MRI. He was just starting his cancer journey, getting scans to figure out what needed to be removed in the next day’s operation. His fear and sense of being overwhelmed were palpable. We talked and shared our stories, and he asked me for my advice (even though he wasn’t dealing with lung cancer). I passed along what was working for me in the moment. I recommended the journaling I do, trying to stay as positive as possible but to not ignore the realities of your cancer and treatments, finding the people that make you feel the best and keeping them in your life, eliminating things that don’t bring you joy or positivity, exercising when and how you can, informing yourself about your diagnosis from reliable sources (DO NOT rely on Dr. Google!), eating well, and watching for the angels in your life. He told me I was an angel for him but in reality, he was an angel for me that day. Seeing him, in raw emotion and having him share his fears with me, let me see myself and also let me see how strong we both were – facing cancer head on.

At the Free to Breathe Walk

My recent triumphs include walking a 5K for Free to Breathe (now merged with the Lung Cancer Research Foundation) and being the number one fundraiser for our walk (and number two in the nation at the time!). I walked that 5K without my cane. I walked that 5K with other survivors and thrivers. I walked that 5K with a widower who buried his wife after her too-short battle with lung cancer. I told my story then, and now, to share with the world, or at least, my corner of it, that lung cancer doesn’t just come for the smokers, the coal miners, or the asbestos workers. Lung cancer claims more lives than breast, prostate and colon cancer, combined. But the research dollars don’t reflect that and need to keep coming in. Funding for other cancers far out paces that for lung cancer yet all it takes for anyone to be at risk for lung cancer is a lung. I want to spread the word and I want research to keep moving forward and staying one step ahead of my cancer so I have more treatment options to keep extending my life for a long time to come.

March 2017

My mother died of lung cancer, and I was secretly worried I would, too.

In spring 2008, I had some puzzling health issues that brought me to number of specialists and finally a pulmonologist. I confessed during one of my appointments that I had smoked for several years, although I had quit 15 years earlier.

He did a spiral CT and told me in no uncertain terms that I did not have lung cancer. We continued the diagnostic journey, and he finally discovered a tracheal stenosis. Yet another specialist treated me with a procedure to dilate the trachea. What a relief it was to breathe more easily – in more ways than one. After many years of wondering, I finally knew that I did not have lung cancer.

A few months later, I started coughing up small amounts of blood. My doctor suspected sinus issues, but to be on the safe side, he went back in to look at my trachea. He found a tumor breaking through the lower lobe into the middle lobe of my right lung.

I had surgery to remove the lower and middle lobes of my lung and was diagnosed with Stage IIIa lung cancer. Following a fairly quick recovery period, I began four rounds of chemotherapy – two weeks on, one week off – with Cysplatin and Gemcytabin. That was hard. I was given a 38% chance of surviving five years. I agreed to participate in a phase 3 clinical trial for Erlotinib – Tarceva. Although my diagnosis was devastating, I knew I could survive.

After treatment, it took me some time to recover. I was working full time and began a vigorous exercise routine. It took about a year to feel healthy and strong again, but I finally felt great. I became quite a vocal lung cancer patient.

I wasn’t prepared for the judging nods that whispered, “Lung cancer? Oh, you smoked, well…” The fact is that my smoking did not cause my lung cancer. My cancer and my mother’s were both caused by radon, which is an issue in my home state of Oregon. I grew up in areas with especially high radon levels. I wanted to put a new face on lung cancer and didn’t hide my diagnosis. I still don’t. I educate others as often as I can about lung cancer and radon, particularly about the disparity in funding for lung cancer research.

Breathing issues return

Six years after treatment – in spring 2015 – I began experiencing new breathing issues. I wasn’t too worried, as all my scans since my first post-surgical exam had been clean. My doctor discovered another tracheal stenosis. I joked, “Be careful now, the last time you went in there, I came out with Stage III lung cancer.”

Little did I know, I had cancer cells in my lung near the original surgical site. Again, I was devastated. But the next day, I took a deep breath and figured out what to do next. The next several months were full of more tests, and even more differing opinions. They could remove the rest of the lung. High dose radiation and chemo had a 90% success rate.

Well, the cancer cells were located too close to my esophagus to risk high dose radiation, so the radiation oncologist was only comfortable with a low dose – which had a 30% success rate. After running multiple tests, my surgeon felt I could tolerate the complete loss of my lung. I chose the surgery, but the day before it was to take place, the surgeon called me with another option. He thought he could get rid of the cells with laser ablation in a simple office visit.

I had the ablation. Unfortunately, a biopsy one month later showed remaining cancer cells, and a new lymph node tested positive. I felt so lost. I didn’t know who to trust or what to do. I knew I needed to decide on my next step, but I didn’t feel capable of making that choice.

Finally, I called my original oncologist, who had moved out of state. I asked him if he would look at my scans and other test results and give me his opinion. A few days later, he called to say he agreed with my current medical oncologist – he felt I should undergo low dose radiation and chemotherapy.

I immediately relaxed and knew that was the right decision. I trusted him, and I was confident I could handle the treatment. After all, I’d done chemo before and radiation couldn’t make it that much different. For six weeks, I underwent daily radiation and chemo – this time it was Cysplatin and Etoposide. I grossly underestimated the side effects of radiation. I’d managed to care for myself during my first bout with lung cancer, but never would have been able to do so the second time without the help of my sister. She was invaluable. I finished treatment almost a year ago. Although I’m not quite 100% better, I’m close.

Hope for the future

I remain optimistic for my future and the future of lung cancer treatment. I’m participating in a phase 2 clinical trial for a lung cancer vaccine, and the data is promising. I’m an active supporter of Free to Breathe (now merged with the Lung Cancer Research Foundation) and its specific focus on lung cancer research. (The photo at the top was taken at the August 2016 run/walk in Portland. My team is Positively Breathtaking!) I hope to work within the state of Oregon to improve the general public’s knowledge of radon and its life-changing effects.

I appreciate the opportunity to share my story with you and would like to ask you to do two things. First, help me reduce the stigma and change the face of lung cancer.

Second, be your own advocate. Listen to your body. Find a healthcare provider that you trust instinctively. Both times I had lung cancer, my body tried to tell me something was wrong. If I had listened to those who recommended I stop at any point along my now eight-year journey, I believe the outcome would have been much more grave.

Springtime twice brought me a lung cancer diagnosis. This spring, I am beginning a new journey that brings me joy. I am frequently reminded of a quote by Christopher Reeve. “Once you choose hope, anything is possible.”

July 2016

As a school teacher, I’m on my feet much of the day and was having some odd symptoms. I was told by the nurse at the school to see a doctor, and when I had passed at out school I was taken to the hospital and later diagnosed with lung cancer. Originally doctors thought it was stage 4 adenocarcinoma, but it was later restaged to stage 1B lung cancer. I was only 29 at the time, and it was all I could think about. I was very anxious and overwhelmed by all of the unknowns associated with my diagnosis.

I ended up having surgery. The top left lobe was removed, and I had 4 rounds of chemotherapy. I was not eligible for a clinical trial, but would have considered one. I had two mutations, but there were no trials at the time. Today, my condition is stable, and I have been blessed with two wonderful children!

After surgery, I had lost my voice and had to adapt to my new lung capacity. This was a big challenge, because as a teacher I needed to be able to yell or read a book at any moment of the day without thinking twice.

Life after treatment was all consuming of my emotions and energy, but I had a strong support system throughout the whole process. My mother took me to all of my appointments, scans and chemotherapy. I leaned on those closest to me. My friends and family were a big help.

I found a few things to help make my journey with lung cancer easier. I avoided reading too much on the internet. There is so much out there, and it can be overwhelming. I also did not ask the doctor questions that I didn’t want to know the answer to. All of the medical terminology was just too overwhelming to me. I put my trust in my medical team.

There are a ton of resources available for people living with other cancers, such as breast and prostate, but very few for lung cancer. It can be hard to find a support group for lung cancer survivors, but I highly recommend getting “plugged in” with one. Just talking to someone who has been there can be helpful, and it can be therapeutic to share your own story.

In the 4 years since my diagnosis, I started Cassie’s Crew in the Dallas Free to Breathe Walk and become an involved advocate, committee member, team captain, donor and ambassador, raising over $110,000 for lung cancer research with my team. It has been a great way to give back and stay connected to the lung cancer community.

May 2017 | As told by Beth

I wasn’t home for Christmas in 2012: I was in the hospital with mysterious respiratory symptoms, and a stubborn “walking pneumonia” that hadn’t responded to antibiotics or steroids.

The new year brought further challenges. Just after New Year’s Day 2013, I received a phone call with the official news that I had been diagnosed with advanced non-small cell lung cancer. I’d had a biopsy while I was in the hospital, so I knew cancer was a possibility. It seemed so impossible, though. All I knew about lung cancer was its association with smoking, and I had never smoked.

I didn’t know anyone with lung cancer or anyone who’d experienced it in their family, or so I thought. I felt alone and didn’t know where to go for help. At first I got most of my information from my doctors and was fortunate to have access to specialists at some of the top cancer centers in the country. When a thoracic surgeon told me that my cancer was Stage IIIb or IV, that I was not a candidate for surgery and that my cancer was not curable, I was devastated.

I will always be grateful to Dr. Biren Saraiya, the medical oncologist who managed my treatment for the first six months. He was patient, compassionate, and knowledgeable. With his help I came to understand that even if my disease couldn’t be cured, with treatment I could have a good quality of life.

When standard chemotherapy didn’t seem to be helping me, Dr. Saraiya encouraged me to find out what clinical trials might be open to me. I knew something about clinical trials from briefly being an AIDS activist in the 1990s, so I understood that trials could be the best way to get access to the newest and most promising treatments. Also, even if a trial medicine didn’t help me, at least by taking part in the trial I could help future patients by contributing to knowledge about this disease.

I had another biopsy, and my cancer tissue was sent off to be tested for any mutation or substance that might provide a clue as to what trial might be best for me. That testing resulted in a wonderful surprise, although at the time I had no idea how wonderful: my cancer had the ROS1 genetic mutation. The data was already showing that one of the new targeted therapies, crizotinib (now better known by the brand name Xalkori), was very effective against ROS1 cancer. The research team enrolled me in the study and I started taking crizotinib right away. The results were amazing: within days I felt better, and within months my cancer was no longer visible on CT scans.

I had never heard of Free to Breathe (now merged with the Lung Cancer Research Foundation) until my friend Michelle signed me up for a lung cancer walk in my hometown, Philadelphia. Years before, I had run a marathon to raise money for the Leukemia and Lymphoma Society in honor of Michelle, a lymphoma survivor. Now the tables were turned, and she organized a team to walk and raise money in my honor. We walked with our mothers and our children, and that year our team was one of the most successful at raising funds.

It’s been important to me to connect with other lung cancer survivors. I’ve taken part in two more Free to Breathe walks, and attended an action summit. I’m part of a lung cancer group on social media (hashtag: #lcsm) and a Facebook group especially for people with the ROS1 mutation. It’s through the community of survivors that I now stay up to date on current treatment news.

I think that this moment in lung cancer history is a little bit like the moment in AIDS history in 1996, when the combined power of engaged patients and inspired activists pushed research over a tipping point and all of a sudden a deadly disease became, for many, a chronic but manageable condition. We may not be quite at that tipping point yet, but I can’t help believing it’s very close.

Photo credit: Donna Uettwiller. Donna was part of Beth’s first Free to Breathe team, and Donna’s daughter won the 5K in her age group.

NEW YORK, November 12, 2019 — Today the Lung Cancer Research Foundation® (LCRF) announced the awardees of its 2019 Scientific Grant Program during the Fourteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City. Through this program, LCRF awarded $2.6 million in research grants to 12 investigators whose projects focus on basic, translational, clinical, health services and epidemiological research. In addition to its annual pilot grants, for the first time, LCRF awarded research grants through two additional funding mechanisms: one focused on overcoming disparities in lung cancer and one on improving the effectiveness of targeted therapies.

LCRF is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. To date, LCRF has funded 370 research grants totaling nearly $34 million, the highest amount provided by an organization dedicated to funding lung cancer research.

“As a lung cancer researcher and former LCRF grantee, I know first-hand the importance and impact LCRF’s funding has on the careers of junior scientists,” said Katerina Politi, PhD, Chair of LCRF’s Scientific Advisory Board and Clinical Biologist and Associate Professor at Yale’s School of Medicine. “Through the grant program, LCRF supports both cutting-edge lung cancer research and researchers. We are confident that these projects will lead to advancements that will ultimately have a direct impact on lung cancer patients.”

Through its annual pilot grant program, LCRF funds innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer. This year, LCRF will be funding four projects through this mechanism. Among them are the prestigious James B. Dougherty Award for Scientific Merit and the William C. Rippe Award for Distinguished Research in Lung Cancer. The James B. Dougherty Award for Scientific Merit is named in honor of Dr. James Dougherty, who served as the Chair of the LCRF Scientific Advisory Board for the past 13 years and is responsible for stewarding the growth of the grant program. The award is presented to the investigator whose proposal was selected for outstanding overall merit by the Foundation’s Scientific Advisory Board. This year’s recipient is Lingtao Jin, PhD, Assistant Professor at the University of Florida in the Department of Anatomy and Cell Biology. Dr. Jin’s research project is titled, “The role of protein kinase signaling in cisplatin-resistant ASCL1-high subtype small cell lung cancer.”

“It is my distinct honor to receive the James B. Dougherty Award for Scientific Merit,” said Dr. Jin. “This award provides critical support and funding to investigate the development of chemotherapy resistance in small cell lung cancer.”

LCRF’s William C. Rippe Award for Distinguished Research in Lung Cancer is presented to the investigator whose proposal not only demonstrated exceptional scientific merit but also exemplified an enduring commitment to making an impact in the field of lung cancer research. Benjamin Lok, MD, Clinician Scientist at the University of Toronto’s Princess Margaret Cancer Centre, was named the 2019 recipient of this award. His research project is titled, “Investigating a resistance mechanism mediated by a Skp, Cullin, F-box containing E3 ubiquitin ligase complex in small cell lung cancer.”

“I am incredibly honored to receive the William C. Rippe Award for Distinguished Research in Lung Cancer from the Lung Cancer Research Foundation,” said Dr. Lok. “This award is a testament to and recognition for the work my laboratory and clinical teams do every day towards the goal of improving outcomes for patients with lung cancer. We do this in partnership with our patients and colleagues – therefore this award is also for them.”

LCRF’s funding mechanism focused on overcoming disparities in lung cancer was founded with support from the Stavros Niarchos Foundation (SNF), in loving memory of Kathryn Louloudis. This year, LCRF will be funding four projects in this area, supported by additional corporate partners, focused on topics including gender, racial, and socioeconomic disparities in care and outcomes. These projects will address important questions across the care continuum and ultimately help to overcome the significant gaps in health equity among lung cancer patients.

Through a collaboration with Pfizer Inc., LCRF will be awarding four research grants focused on understanding ways to improve clinical practices for managing side effects in patients with non-small cell lung cancer (NSCLC) who are receiving targeted therapies. These research projects will leverage multidisciplinary approaches to help patients and their care teams manage side effects and receive the maximum possible benefit of these important therapies. This Lung Cancer Treatment Focused Research Grant Program is the first collaboration of its kind in lung cancer and is very important and timely to the many patients receiving targeted therapies.

In addition to the presentation of the 2019 Scientific Grant Program awards, LCRF’s Lung Cancer Awareness Luncheon featured two guest speakers. Giuseppe Giaccone, MD, PhD, Associate Director for Clinical Research at Cornell University delivered the keynote address. LCRF Board Member and lung cancer survivor Reina Honts shared her experience and talked about the importance of research funding and early detection.

The 2019 Pilot Grant Program award recipients include*:

Alice Berger, PhD
Fred Hutchinson Cancer Research Center
Novel strategies for therapeutic target discovery in lung cancer

Lingtao Jin, PhD
University of Florida
The role of protein kinase signaling in cisplatin-resistant ASCL1-high subtype SCLC

Benjamin Lok, MD
Princess Margaret Cancer Centre, University of Toronto
Investigating a resistance mechanism mediated by a Skp, Cullin, F-box containing E3 ubiquitin ligase complex in small cell lung cancer

Zhan Yao, PhD
Memorial Sloan Kettering Cancer Center
Studies on the oncogenic function and mediation of drug resistance by ARAF in lung cancer

The 2019 Disparities in Lung Cancer Research Grant Program award recipients include*:

Melinda Aldrich, PhD, MPH
Vanderbilt University Medical Center
Identifying determinants of racial disparities in lung cancer stage

Manali Patel, PhD, MPH
Stanford University
Reducing disparities in lung cancer through community partnerships

Betsy Risendal, PhD
University of Colorado Denver
Improving preventive care to address lung cancer disparities

Rajwanth Veluswamy, MD
Icahn School of Medicine at Mount Sinai
Assessing the mechanisms underlying the association between sex and immunotherapy response

The 2019 Lung Cancer Treatment Focused Research Grant Program award recipients include**:

Ryan Gentzler, MD
University of Virginia
Real-time monitoring and modeling of symptoms and adverse events in lung cancer patients receiving oral targeted therapies for tumors with oncogenic driver mutations

Nisha Mohindra, MD
Northwestern University Feinberg School of Medicine
Using the novel 4R patient care sequences to improve the duration and outcomes of therapy in NSCLC patients receiving targeted treatment

Katharine Rendle, PhD, MSW, MPH
University of Pennsylvania
Implementation strategies for monitoring adherence in real-time (iSMART)

Christian Rolfo, MD, PhD, MBA
University of Maryland, Baltimore
Proactive monitoring of treatment related adverse events through a mobile application in NSCLC patients treated with tyrosine kinase inhibitors: the “Empower Me” Digital Therapeutic Study

For more information about LCRF and the Scientific Grant Program, visit lcrf.org.

*These grants provide up to $150,000 in funding over a two-year period
** These grants provide up to $350,000 in funding over a two-year period

###

About the Lung Cancer Research Foundation®
The Lung Cancer Research Foundation (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has funded 370 research grants, totaling nearly $34 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. For more information, visit lcrf.org.

NEW YORK (November 8, 2019) —In the United States, lung cancer claims more women’s lives each year than breast, ovarian, and cervical cancers combined. In many countries around the world, it has become the leading cause of cancer death in women. This November and December, the Lung Cancer Research Foundation® (LCRF) is shining a spotlight on women and lung cancer, with the goal of educating the public about these staggering statistics.

“Everyone has women in their life—a loved one, friend, co-worker—so this disease truly does impact everyone,” said Joan H. Schiller, MD, Chair of LCRF’s Scientific Steering Committee. “Our goal is to raise awareness to better understand lung cancer risks, particularly for women, and improve outcomes for those diagnosed.”

Worldwide, lung cancer is the leading cause of cancer mortality in women and over 500,000 women die of the disease each year. While lung cancer incidence remains lower in women than in men, the gap has been narrowing in recent years. With a higher proportion of lung cancer among nonsmokers occurring in women, these are troubling statistics. In an effort to raise awareness, LCRF has created a page on its website dedicated to women and lung cancer, http://lcrf.org/women. Visitors will learn the facts about lung cancer and will have the opportunity to read stories of women currently living with lung cancer.

LCRF is the leading nonprofit organization focused on funding innovative, high-reward lung cancer research with the potential to extend survival and improve quality of life for people with lung cancer. The organization’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. This campaign, focused on women and lung cancer, will help to highlight an important area that warrants additional study. “By talking about these grim statistics, we hope to raise awareness and highlight the importance of research and how lung cancer is affecting women,” said Schiller.

To learn more information and download a fact sheet on women and lung cancer, visit http://lcrf.org/women. This initiative is sponsored by Bristol-Meyers Squibb, Genentech and Takeda Oncology.

# # #

About the Lung Cancer Research Foundation

The Lung Cancer Research Foundation® (LCRF) is the leading nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer.

To date, LCRF has provided $33 million in research grants to investigators around the world. In addition to funding lung cancer research, the organization focuses on lung cancer awareness and educational programs. The Foundation also hosts community events nationwide through the Free to Breathe Events Program. For more information, visit http://lcrf.org.